Green Thumb Industries (GTBIF) Operating Expenses (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Operating Expenses came in at $102.9 million in Q1 2026, up 2.1% YoY from $100.8 million in Q1 2025, and down 15.85% on a QoQ basis from $122.3 million in Q4 2025.
Green Thumb Industries (GTBIF) Operating Expenses (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Operating Expenses data on file, last reported at $102.9 million in Q1 2026.
- Quarterly Operating Expenses rose 2.1% year-over-year to $102.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $439.3 million (up 8.95% YoY) and the FY2025 annual result came in at $437.2 million, up 16.06% from the prior year.
- Operating Expenses slipped to $102.9 million in Q1 2026, from $122.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $168.5 million in Q4 2022 to a low of $63.5 million in Q2 2022.
- A 5-year average of $96.6 million and a median of $96.5 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 126.93% — and 2023, when it sank 45.19%.
- Tracing GTBIF's Operating Expenses over 5 years: stood at $168.5 million in 2022, then slumped by 45.19% to $92.3 million in 2023, then advanced by 9.32% to $101.0 million in 2024, then grew by 21.13% to $122.3 million in 2025, then slipped by 15.85% to $102.9 million in 2026.
- The last three Operating Expenses figures came in at $102.9 million (Q1 2026), $122.3 million (Q4 2025), and $107.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 117.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 117.91 Mn |
| Mar 31, 2026 | 102.91 Mn |
| Dec 31, 2025 | 122.29 Mn |
| Sep 30, 2025 | 107.29 Mn |
| Jun 30, 2025 | 106.82 Mn |
| Mar 31, 2025 | 100.79 Mn |
| Dec 31, 2024 | 100.96 Mn |
| Sep 30, 2024 | 104.97 Mn |
| Jun 30, 2024 | 96.50 Mn |
| Mar 31, 2024 | 74.26 Mn |
| Dec 31, 2023 | 92.35 Mn |
| Sep 30, 2023 | 84.78 Mn |
| Jun 30, 2023 | 84.22 Mn |
| Mar 31, 2023 | 80.52 Mn |
| Dec 31, 2022 | 168.50 Mn |
| Sep 30, 2022 | 82.48 Mn |
| Jun 30, 2022 | 63.54 Mn |
| Mar 31, 2022 | 68.39 Mn |
| Dec 31, 2021 | 74.25 Mn |
| Sep 30, 2021 | 71.45 Mn |